Promising treatment for chronic fatigue syndrome fails large trial

    9
    0
    SHARE
    Promising treatment for chronic fatigue syndrome fails large trial


    Health



    9 April 2019

    GettyImages-1128717642

    iStock / Getty Images Plus

    By Clare Wilson

    A medicine that people hoped would treat chronic fatigue syndrome (CFS) has failed its first large placebo-controlled trial.

    The drug, called rituximab, is used to treat cancer and autoimmune diseases in which the immune system makes antibodies that turn against the body. The medicine works by killing the cells that make antibodies.

    Advertisement

    A few people who had cancer and also happened to have CFS saw their symptoms of fatigue resolve after taking rituximab. Øystein Fluge of Haukeland University Hospital in Norway thought …

    Quarterly by Direct Debit

    Inclusive of applicable taxes (VAT)

    Read More

    Leave a Reply